CCM
PROF

Connective Capital Management’s Profound Medical PROF Stock Holding History

Connective Capital Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,000
Closed -$787K – 79
2025
Q4 		$787K Buy
+100,000
New +$643K 0.46% 23

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Connective Capital Management's PROF Position: Q1 2026 in Review

Connective Capital Management sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 100,000 shares — an estimated $787K sold.

Connective Capital Management first reported a position in PROF in Q4 2025 and held it in 1 quarter. The position peaked at $787K in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Connective Capital Management reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Connective Capital Management sold 100,000 Profound Medical shares in Q1 2026, an estimated $787K.
  • Connective Capital Management first reported a position in Profound Medical in Q4 2025 and held it in 1 quarter.
  • Connective Capital Management's Profound Medical position peaked at $787K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Connective Capital Management's 13F filing for Q1 2026, filed 13 May 2026.